Advertisement
Screener

Eagle Pharmaceuticals, Inc. Patents: Active

Eagle Pharmaceuticals, Inc. Active Patents

12 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-02-24: Application 19061465; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Patented Case.
  • 2024-04-25: Application 18646329; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Patented Case.
  • 2024-04-25: Application 18646171; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Patented Case.
  • 2023-09-20: Application 18470952; Invention PEMETREXED FORMULATIONS; Applicant Eagle Pharmaceuticals, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-02-2419061465FORMULATIONS OF BENDAMUSTINEEagle Pharmaceuticals, Inc.Patented Case2025-07-0812350257US20250186402A1
Nagesh R. PALEPU
Philip Christopher BUXTON
United States
United Kingdom
ARNOLD, ERNST V
2024-04-2518646329FORMULATIONS OF BENDAMUSTINEEagle Pharmaceuticals, Inc.Patented Case2025-07-0112343333US20240293373A1
Nagesh R. Palepu
Philip Christopher Buxton
United States
United Kingdom
ARNOLD, ERNST V
2024-04-2518646171FORMULATIONS OF BENDAMUSTINEEagle Pharmaceuticals, Inc.Patented Case2024-11-1212138248US20240293372A1
Nagesh R. Palepu
Philip Christopher Buxton
United States
United Kingdom
ARNOLD, ERNST V
2023-09-2018470952PEMETREXED FORMULATIONSEagle Pharmaceuticals, Inc.Patented Case2024-10-1512115164US20240009199A1
Feng-Jing CHEN
Steven L. KRILL
United States
United States
LEE, WILLIAM Y
2023-02-1418109421FULVESTRANT FORMULATIONS AND METHODS OF THEIR USEEAGLE PHARMACEUTICALS, INC.Patented Case2025-01-0712186427US20230404918A1
Feng-Jing CHEN
Steven L. KRILL
Rama Abu SHMEIS
Adrian HEPNER
Charles WESCOTT
Tara JASKOWSKI
Michael JOYCE
United States
United States
United States
United States
United States
United States
United States
MERCIER, MELISSA S
2022-12-1418081251FORMULATIONS OF BENDAMUSTINEEagle Pharmaceuticals, Inc.Patented Case2024-01-1611872214US20230115693A1
Nagesh R. Palepu
Philip Christopher Buxton
United States
United Kingdom
ARNOLD, ERNST V
2022-12-1418081238FORMULATIONS OF BENDAMUSTINEEagle Pharmaceuticals, Inc.Patented Case2023-12-1911844783US20230115164A1
Nagesh R. Palepu
Philip Christopher Buxton
United States
United Kingdom
ARNOLD, ERNST V
2022-10-0617995604METHODS OF TREATING SEVERE ACUTE RESPIRATORY SYNDROMEEAGLE PHARMACEUTICALS, INC.Patented Case2026-03-2412582633US20230149363A1
Adrian HEPNER
United States
TOWNSLEY, SARA ELIZABETH
2022-10-0617995602METHODS OF TREATING SARS-COV-2 INFECTIONSEAGLE PHARMACEUTICALS, INC.Patented Case2026-04-2112605364US20230144719A1
Adrian HEPNER
United States
TOWNSLEY, SARA ELIZABETH
2022-06-0817835236PEMETREXED FORMULATIONSEagle Pharmaceuticals, Inc.Patented Case2023-10-2411793813US20220296603A1
Feng-Jing Chen
Steven L. Krill
United States
United States
VANHORN, ABIGAIL LOUISE
2021-11-1817529791FULVESTRANT FORMULATIONSEagle Pharmaceuticals, Inc.Patented Case2025-07-0812350339US20220072132A1
Bulusu Bhanu Teja
Nagesh R. Palepu
India
United States
LEE, ANDREW P
2021-07-1917379534FULVESTRANT FORMULATIONS AND METHODS OF THEIR USEEAGLE PHARMACEUTICALS, INC.Patented Case2025-07-2912370199US20210346396A1
Feng-Jing Chen
Steven L. Krill
Rama Abu Shmeis
United States
United States
United States
TCHERKASSKAYA, OLGA V